Cargando…

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment

Multiple sclerosis (MS) treatment options have improved significantly over the past decades, but the consequences of MS can still be devastating and the needs for monitoring treatment surveillance are considerable. In the current study we used affinity proteomics technology to identify potential bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bedri, Sahl Khalid, Nilsson, Ola B., Fink, Katharina, Månberg, Anna, Hamsten, Carl, Ayoglu, Burcu, Manouchehrinia, Ali, Nilsson, Peter, Olsson, Tomas, Hillert, Jan, Grönlund, Hans, Glaser, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541274/ https://www.ncbi.nlm.nih.gov/pubmed/31141529 http://dx.doi.org/10.1371/journal.pone.0217208

Ejemplares similares

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
por: McKay, Kyla A., et al.
Publicado: (2022)

Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study
por: Karrenbauer, Virginija Danylaité, et al.
Publicado: (2021)

Copy number variations across the blood–brain barrier in multiple sclerosis
por: Bedri, Sahl Khalid, et al.
Publicado: (2022)

Autoantibody Profiling in Multiple Sclerosis Using Arrays of Human Protein Fragments
por: Ayoglu, Burcu, et al.
Publicado: (2013)

Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
por: Hamsten, Carl, et al.
Publicado: (2016)

Association of Pre-Disease Body Mass Index With Multiple Sclerosis Prognosis
por: Manouchehrinia, Ali, et al.
Publicado: (2018)

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
por: Asplund Högelin, Klara, et al.
Publicado: (2021)

Determinants of quality of life in pediatric- and adult-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2020)

Smoking Attributable Risk in Multiple Sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2022)

Income in Multiple Sclerosis Patients with Different Disease Phenotypes
por: Kavaliunas, Andrius, et al.
Publicado: (2017)

Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context
por: He, Anna, et al.
Publicado: (2023)

Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
por: He, Anna H, et al.
Publicado: (2023)

False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases
por: Kharlamova, Nastya, et al.
Publicado: (2021)

The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case–control study
por: Boles, Graysen Steele, et al.
Publicado: (2023)

The Temporal Retinal Nerve Fiber Layer Thickness Is the Most Important Optical Coherence Tomography Estimate in Multiple Sclerosis
por: Birkeldh, Ulrika, et al.
Publicado: (2017)

Season of birth is associated with multiple sclerosis and disease severity
por: Stridh, P, et al.
Publicado: (2021)

Age Related Multiple Sclerosis Severity Score: Disability ranked by age
por: Manouchehrinia, Ali, et al.
Publicado: (2017)

Accurate classification of secondary progression in multiple sclerosis using a decision tree
por: Ramanujam, Ryan, et al.
Publicado: (2020)

Long-term disability progression of pediatric-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2019)

Depression and multiple sclerosis: A bidirectional Mendelian randomisation study
por: Binzer, Stefanie, et al.
Publicado: (2021)

Smoking and multiple sclerosis susceptibility
por: Hedström, Anna Karin, et al.
Publicado: (2013)

Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden
por: Karampampa, Korinna, et al.
Publicado: (2022)

Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis
por: Bronge, Mattias, et al.
Publicado: (2022)

Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study
por: He, Anna, et al.
Publicado: (2023)

Multiplexed protein profiling by sequential affinity capture
por: Ayoglu, Burcu, et al.
Publicado: (2016)

Importance of early treatment decisions on future income of multiple sclerosis patients
por: Kavaliunas, Andrius, et al.
Publicado: (2020)

Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis
por: Hedström, Anna Karin, et al.
Publicado: (2021)

Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2020)

Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort study
por: Manouchehrinia, Ali, et al.
Publicado: (2023)

A multiple sclerosis disease progression measure based on cumulative disability
por: Manouchehrinia, Ali, et al.
Publicado: (2021)

Levels of human proteins in plasma associated with acute paediatric malaria
por: Reuterswärd, Philippa, et al.
Publicado: (2018)

Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
por: Manouchehrinia, Ali, et al.
Publicado: (2020)

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
por: Binzer, Stefanie, et al.
Publicado: (2019)

In Vitro Evolution of Allergy Vaccine Candidates, with Maintained Structure, but Reduced B Cell and T Cell Activation Capacity
por: Nilsson, Ola B., et al.
Publicado: (2011)

Low sun exposure increases multiple sclerosis risk both directly and indirectly
por: Hedström, Anna Karin, et al.
Publicado: (2019)

Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression
por: Wu, Jing, et al.
Publicado: (2023)

Correction: In Vitro Evolution of Allergy Vaccine Candidates, with Maintained Structure, but Reduced B Cell and T Cell Activation Capacity
por: Nilsson, Ola B., et al.
Publicado: (2012)

Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis
por: Thomas, Olivia G., et al.
Publicado: (2023)

Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
por: Signorelli, Mirko, et al.
Publicado: (2019)

Sensitive detection of antigen-specific T-cells using bead-bound antigen for in vitro re-stimulation
por: Bronge, Mattias, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_37ta1fau2am7og98cg3bb9jcug